1 | 1 | | 85R11960 SMT-F |
---|
2 | 2 | | By: Buckingham S.B. No. 1375 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to the use of clinical decision support software and |
---|
8 | 8 | | laboratory benefits management programs by physicians and health |
---|
9 | 9 | | care providers in connection with provision of clinical laboratory |
---|
10 | 10 | | services to health benefit plan enrollees. |
---|
11 | 11 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
12 | 12 | | SECTION 1. Chapter 1451, Insurance Code, is amended by |
---|
13 | 13 | | adding Subchapter M to read as follows: |
---|
14 | 14 | | SUBCHAPTER M. CLINICAL LABORATORIES |
---|
15 | 15 | | Sec. 1451.601. DEFINITIONS. In this subchapter: |
---|
16 | 16 | | (1) "Clinical decision support software" means |
---|
17 | 17 | | computer software that compares patient characteristics to a |
---|
18 | 18 | | database of clinical knowledge to produce patient-specific |
---|
19 | 19 | | assessments or recommendations to assist a physician or health care |
---|
20 | 20 | | provider in making clinical decisions. |
---|
21 | 21 | | (2) "Clinical laboratory service" means the |
---|
22 | 22 | | examination of a sample of biological material taken from a human |
---|
23 | 23 | | body ordered by a physician or health care provider for use in the |
---|
24 | 24 | | diagnosis, prevention, or treatment of a disease or the |
---|
25 | 25 | | identification or assessment of a medical or physical condition. |
---|
26 | 26 | | (3) "Enrollee" means an individual enrolled in a |
---|
27 | 27 | | health benefit plan. |
---|
28 | 28 | | (4) "Health benefit plan issuer" means an entity |
---|
29 | 29 | | authorized under this code or another insurance law of this state to |
---|
30 | 30 | | provide health insurance or another form of health benefit plan in |
---|
31 | 31 | | this state, including: |
---|
32 | 32 | | (A) an insurance company; |
---|
33 | 33 | | (B) a group hospital service corporation |
---|
34 | 34 | | operating under Chapter 842; |
---|
35 | 35 | | (C) a health maintenance organization operating |
---|
36 | 36 | | under Chapter 843; |
---|
37 | 37 | | (D) an approved nonprofit health corporation |
---|
38 | 38 | | that holds a certificate of authority under Chapter 844; |
---|
39 | 39 | | (E) a multiple employer welfare arrangement that |
---|
40 | 40 | | holds a certificate of authority under Chapter 846; |
---|
41 | 41 | | (F) a stipulated premium company operating under |
---|
42 | 42 | | Chapter 884; |
---|
43 | 43 | | (G) a fraternal benefit society operating under |
---|
44 | 44 | | Chapter 885; |
---|
45 | 45 | | (H) a Lloyd's plan operating under Chapter 941; |
---|
46 | 46 | | or |
---|
47 | 47 | | (I) an exchange operating under Chapter 942. |
---|
48 | 48 | | (5) "Laboratory benefits management program" means a |
---|
49 | 49 | | health benefit plan issuer protocol or program administered by the |
---|
50 | 50 | | health benefit plan issuer or an entity under contract with the |
---|
51 | 51 | | health benefit plan issuer that dictates or limits decision making |
---|
52 | 52 | | by a physician or health care provider relating to the use of |
---|
53 | 53 | | clinical laboratory services. |
---|
54 | 54 | | Sec. 1451.602. CERTAIN REQUIREMENTS FOR USE OF CLINICAL |
---|
55 | 55 | | LABORATORIES AND LABORATORY SERVICES PROHIBITED. (a) A health |
---|
56 | 56 | | benefit plan issuer may not require the use of clinical decision |
---|
57 | 57 | | support software or a laboratory benefits management program by an |
---|
58 | 58 | | enrollee's physician or health care provider before the physician |
---|
59 | 59 | | or health care provider orders a clinical laboratory service for |
---|
60 | 60 | | the enrollee. |
---|
61 | 61 | | (b) A health benefit plan issuer may not direct or limit the |
---|
62 | 62 | | decision making of an enrollee's physician or health care provider |
---|
63 | 63 | | relating to the use of a clinical laboratory service or referral of |
---|
64 | 64 | | a patient specimen to a laboratory in the health benefit plan |
---|
65 | 65 | | network or otherwise designated by the health benefit plan issuer. |
---|
66 | 66 | | (c) A health benefit plan issuer may not limit or deny |
---|
67 | 67 | | payment for a clinical laboratory service based on whether the |
---|
68 | 68 | | ordering physician or health care provider uses clinical decision |
---|
69 | 69 | | support software or a laboratory benefits management program. |
---|
70 | 70 | | SECTION 2. Subchapter M, Chapter 1451, Insurance Code, as |
---|
71 | 71 | | added by this Act, applies to a contract that is entered into or |
---|
72 | 72 | | renewed on or after the effective date of this Act. A contract |
---|
73 | 73 | | entered into or renewed before the effective date of this Act is |
---|
74 | 74 | | governed by the law as it existed immediately before the effective |
---|
75 | 75 | | date of this Act, and that law is continued in effect for that |
---|
76 | 76 | | purpose. |
---|
77 | 77 | | SECTION 3. This Act takes effect September 1, 2017. |
---|